| 000 | 01289cam a2200217 4500 | ||
|---|---|---|---|
| 001 | 9780323612128 | ||
| 008 | 220107t2021 xxu||||| |||| 00| 0 eng d | ||
| 020 | _a9780323612128 | ||
| 020 | _a9780323612111 | ||
| 041 | _aeng | ||
| 100 | _aWolverton, Stephen E. | ||
| 245 | 0 | _aComprehensive dermatologic drug therapy | |
| 250 | _a4th ed. | ||
| 260 |
_aPhiladelphia : _bElsevier, _c2021 |
||
| 300 | _a1 online resource:illustrations (some color) | ||
| 505 | _apt. I. Introduction -- pt. II. Important drug regulatory issues -- pt. III. Systemic drugs for infectious diseases -- pt. IV. Systemic immunomodulatory drugs -- pt. V. Drugs used in conjunction with UV or visible light -- pt. VI. Biological therapeutics -- pt. VII. Miscellaneous systemic drugs -- pt. VIII. Topical drugs for infectious diseases -- pt. IX. Topical immunomodulatory drugs -- pt. X. Miscellaneous topical drugs -- pt. XI. Injectable and mucosal routes of drug administration -- pt. XII. Major adverse effects from systemic drugs -- pt. XIII. Special pharmacology and therapeutic topics." | ||
| 690 | _aDermatopharmacology. | ||
| 700 | _aWu, Jashin J. | ||
| 856 | _uhttps://go.openathens.net/redirector/nhs?url=https://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C20141020972 | ||
| 999 |
_c58243 _d58243 |
||